Bacteria and derived products to strengthen defences and reduce risk of illness
[EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses. The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation.
Main Authors: | , , , |
---|---|
Format: | solicitud de patente biblioteca |
Language: | Spanish / Castilian |
Published: |
2010-01-21
|
Subjects: | Bifidobacterium, |
Online Access: | http://hdl.handle.net/10261/27263 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-iata-es-10261-27263 |
---|---|
record_format |
koha |
spelling |
dig-iata-es-10261-272632019-10-23T09:45:33Z Bacteria and derived products to strengthen defences and reduce risk of illness Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad Sanz Herranz, Yolanda Palma, Giada de Sánchez Sánchez, Esther Medina, Marcela Susana Bifidobacterium [EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses. The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation. [ES] Esta invención aporta una nueva cepa del género Bifidobacteríum y los componentes de sus sobrenadantes de cultivo en forma de diversos preparados (alimentos funcionales y nuevos, probióticos, simbióticos, suplementos, nutracéuticos, y fármacos) destinados a mejorar las defensas y reducir el riesgo de enfermedad. Sus mecanismos de acción incluyen: (i) la regulación de la glicosilación intestinal favoreciendo la propia de individuos sanos, (ii) la modulación de las interacciones entre las células epiteliales y la microbiota intestinal, favoreciendo la adhesión de bifidobacterias beneficiosas y (iii) regulando la respuestas inmunológicas. Los productos incluidos son estables en condiciones gastrointestinales y tecnológicas, garantizando su explotación. Peer reviewed Consejo Superior de Investigaciones Científicas (España) A1 Solicitud de patentes con informe sobre el estado de la técnica 2010-08-25T11:22:31Z 2010-08-25T11:22:31Z 2010-01-21 2008-07-15 solicitud de patente WO2010007198 A1 http://hdl.handle.net/10261/27263 PCT/ES2009/070285 es open 1530505 bytes application/pdf |
institution |
IATA ES |
collection |
DSpace |
country |
España |
countrycode |
ES |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-iata-es |
tag |
biblioteca |
region |
Europa del Sur |
libraryname |
Biblioteca del IATA España |
language |
Spanish / Castilian |
topic |
Bifidobacterium Bifidobacterium |
spellingShingle |
Bifidobacterium Bifidobacterium Sanz Herranz, Yolanda Palma, Giada de Sánchez Sánchez, Esther Medina, Marcela Susana Bacteria and derived products to strengthen defences and reduce risk of illness |
description |
[EN] This invention provides a new strain of the genus Bifidobacterium and the components of the cultivation supernatants thereof in the form of diverse preparations (functional and new foods, probiotics, symbiotics, supplements, nutraceuticals and drugs) destined to improve defences and reduce the risk of illness. The mechanisms of action thereof include: (i) regulation of intestinal glycosylation promoting that of healthy individuals, (ii) modulation of interactions between epithelial
cells and intestinal microbiota promoting adhesion of beneficia1 bifidobacteria and (iii) regulation of immunological responses.
The products included are stable in gastrointestinal and technological conditions, ensuring their exploitation. |
format |
solicitud de patente |
topic_facet |
Bifidobacterium |
author |
Sanz Herranz, Yolanda Palma, Giada de Sánchez Sánchez, Esther Medina, Marcela Susana |
author_facet |
Sanz Herranz, Yolanda Palma, Giada de Sánchez Sánchez, Esther Medina, Marcela Susana |
author_sort |
Sanz Herranz, Yolanda |
title |
Bacteria and derived products to strengthen defences and reduce risk of illness |
title_short |
Bacteria and derived products to strengthen defences and reduce risk of illness |
title_full |
Bacteria and derived products to strengthen defences and reduce risk of illness |
title_fullStr |
Bacteria and derived products to strengthen defences and reduce risk of illness |
title_full_unstemmed |
Bacteria and derived products to strengthen defences and reduce risk of illness |
title_sort |
bacteria and derived products to strengthen defences and reduce risk of illness |
publishDate |
2010-01-21 |
url |
http://hdl.handle.net/10261/27263 |
work_keys_str_mv |
AT sanzherranzyolanda bacteriaandderivedproductstostrengthendefencesandreduceriskofillness AT palmagiadade bacteriaandderivedproductstostrengthendefencesandreduceriskofillness AT sanchezsanchezesther bacteriaandderivedproductstostrengthendefencesandreduceriskofillness AT medinamarcelasusana bacteriaandderivedproductstostrengthendefencesandreduceriskofillness AT sanzherranzyolanda bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad AT palmagiadade bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad AT sanchezsanchezesther bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad AT medinamarcelasusana bacteriasyproductosderivadosparafortalecerlasdefensasyreducirelriesgodeenfermedad |
_version_ |
1777669958667337728 |